← brief for 2026-10-10 · Slowing decline

Renoprotective vs. Antihypertensive Dosing of Renin–Angiotensin System Inhibitors in Chronic Kidney Disease: Analysis of Summary of Product Characteristics of Medicinal Products Authorized in Poland

Article No results yet Peer reviewed

Key takeaways

This study checked the official drug labels for blood pressure medicines in Poland. It looked at how the labels suggest dosing for people with kidney disease. It is a review of documents, not a clinical trial with patient results.

Who did this work

Marta Maciejczyk (Medical University of Warsaw) · Anna Maria Dworakowska (Medical University of Warsaw) · Magdalena Bujalska-Zadrożny (Medical University of Warsaw)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-09
https://doi.org/10.3390/jcm15207771